Genomic and Proteomic Analyses of Aggressive Tumors

Overview

About this study

The purpose of this study is to use genomic and proteomic analyses to identify possible diagnostic markers and potential drugs for diagnosing and treating aggressive tumor types or neoplastic processes. Genomic analyses mean looking at the genome, or all the DNA in a cell (DNA is a material in your body that is a genetic map or code that provides instructions that make up your genes). Proteomic analyses mean looking at the proteome, or all the proteins expressed, or made, by DNA at a specific moment in time

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients with aggressive/metastatic tumors or patients with LAM disease.

Exclusion Criteria: 

  • Patients with indolent tumors.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 10/23/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

George Vasmatzis, Ph.D.

Open for enrollment

Contact information:

Angela Emanuel

(507) 538-0920

Emanuel.Angela@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

Panagiotis Anastasiadis, Ph.D.

Open for enrollment

Contact information:

Angela Emanuel

(507) 538-0920

Emanuel.Angela@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Mitesh Borad, M.D.

Open for enrollment

Contact information:

Angela Emanuel

(507) 538-0920

Emanuel.Angela@mayo.edu

More information

Publications

Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions